Effect of aflibercept in patients with age-related macular degeneration.

about

Effect of aflibercept in patients with age-related macular degeneration.

Item

http://www.wikidata.org/entity/Q55057323

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Effect of aflibercept in patients with age-related macular degeneration.

@en

Effect of aflibercept in patients with age-related macular degeneration.

@nl

type

Item

label

Effect of aflibercept in patients with age-related macular degeneration.

@en

Effect of aflibercept in patients with age-related macular degeneration.

@nl

prefLabel

Effect of aflibercept in patients with age-related macular degeneration.

@en

Effect of aflibercept in patients with age-related macular degeneration.

@nl

P1476

Effect of aflibercept in patients with age-related macular degeneration.

@en

P2093

Aki Kondo

http://www.w3.org/2001/XMLSchema#string

Hiroko Okuma

http://www.w3.org/2001/XMLSchema#string

Maiko Yoshida

http://www.w3.org/2001/XMLSchema#string

Mari Goto

http://www.w3.org/2001/XMLSchema#string

Masao Matsubara

http://www.w3.org/2001/XMLSchema#string

Tatsuya Mimura

http://www.w3.org/2001/XMLSchema#string

Yuko Kamei

http://www.w3.org/2001/XMLSchema#string

P2860

Posterior vitreous detachment following intravitreal drug injection.

Drug delivery to the posterior segment of the eye for pharmacologic therapy.

Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.

Visual and anatomical outcomes of intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration.

Aflibercept for the treatment of age-related macular degeneration.

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study.

Pharmacologic vitreodynamics and molecular flux.

Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics.

Factors associated with the response of age-related macular degeneration to intravitreal ranibizumab treatment.

P2888

s10792-015-0089-z

P304

159-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10792-015-0089-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010859821

http://www.w3.org/2001/XMLSchema#string

P698

26043678

http://www.w3.org/2001/XMLSchema#string